Development of Hepatitis C virus genotyping by real-time PCR based on the NS5B region

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Nakatani, Sueli M ^a,g   Santos, Carlos A ^b   Riediger, Irina N ^a,e   Krieger, Marco A ^c   Duarte, Cesar A B ^c   Lacerda, Marco A ^d   Biondo, Alexander W ^e,f   Carilho, Flair J ^g   Ono Nita, Suzane K ^g  

^a Bacteriology Section   (Brazil)

^b Centro de Genomas   (Brazil)

^c INSTITUTO CARLOS CHAGAS   (Brazil)

^d INDIANA UNIVERSITY   (United States)

^e FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 5B; VIRUS RNA; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS DNA; VIRUS PROTEIN;

ACCURACY; ARTICLE; BRAZIL; CONTROLLED STUDY; COST CONTROL; FEASIBILITY STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; VALIDATION PROCESS; VIRUS CHARACTERIZATION; VIRUS IDENTIFICATION; VIRUS TYPING; DRUG MONITORING; ECONOMICS; GENETICS; HEPATITIS C; LIMIT OF DETECTION; METHODOLOGY; POLYMERASE CHAIN REACTION;

HEPATITIS C VIRUS;

DNA, VIRAL; DRUG MONITORING; GENOTYPE; HEPACIVIRUS; HEPATITIS C; LIMIT OF DETECTION; POLYMERASE CHAIN REACTION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 77956327468     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010150     Document Type: Article

References (24)

1. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, et al. (1998) Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 352(9138): 1426-1432.
2. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, et al. (1995) Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 59 non-coding region. J Gen Virol 76 (Pt 5): 1197-1204.
3. Murphy DG, Willems B, Deschenes M, Hilzenrat N, Mousseau R, et al. (2007) Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 59 untranslated region sequences. J Clin Microbiol 45(4): 1102-1112.
4. Cantaloube JF, Laperche S, Gallian P, Bouchardeau F, de Lamballerie X, et al. (2006) Analysis of the 59 noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J Clin Microbiol 44(6): 2051-2056.
5. Simmonds P (2004) Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 85(Pt 11): 3173-3188.
6. Weck K (2005) Molecular methods of hepatitis C genotyping. Expert Rev Mol Diagn 5(4): 507-520.
7. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, et al. (1994) A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19(5): 1321-1324.
8. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonak J, et al. (2006) The real-time polymerase chain reaction. Mol Aspects Med 27(2-3): 95-125.
9. Lindh M, Hannoun C (2005) Genotyping of hepatitis C virus by Taqman realtime PCR. J Clin Virol 34(2): 108-114.
10. Rolfe KJ, Alexander GJ, Wreghitt TG, Parmar S, Jalal H, et al. (2005) A realtime Taqman method for hepatitis C virus genotyping. J Clin Virol 34(2): 115-121.
11. Schroter M, Zollner B, Schafer P, Landt O, Lass U, et al. (2002) Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes. J Clin Microbiol 40(6): 2046-2050.
12. Bullock GC, Bruns DE, Haverstick DM (2002) Hepatitis C genotype determination by melting curve analysis with a single set of fluorescence resonance energy transfer probes. Clin Chem 48(12): 2147-2154.
13. Fujigaki H, Takemura M, Takahashi K, Yamada Y, Fujii H, et al. (2004) Genotyping of hepatitis C virus by melting curve analysis with SYBR Green I. Ann Clin Biochem 41(Pt 2): 130-132.
14. Cook L, Sullivan K, Krantz EM, Bagabag A, Jerome KR (2006) Multiplex realtime reverse transcription-PCR assay for determination of hepatitis C virus genotypes. J Clin Microbiol 44(11): 4149-4156.
15. Stahlberg A, Kubista M, Pfaffl M (2004a) Comparison of reverse transcriptases in gene expression analysis. Clin Chem 50(9): 1678-1680.
16. Peters IR, Helps CR, Hall EJ, Day MJ (2004) Real-time RT-PCR: considerations for efficient and sensitive assay design. J Immunol Methods 286(1-2): 203-217.
17. Stahlberg A, Hakansson J, Xian X, Semb H, Kubista M (2004b) Properties of the reverse transcription reaction in mRNA quantification. Clin Chem 50(3): 509-515.
18. Campiotto S, Pinho JR, Carrilho FJ, Da Silva LC, Souto FJ, et al. (2005) Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 38(1): 41-49.
19. Levi JE, Takaoka DT, Garrini RH, Fachini RM, Focaccia R, et al. (2002) Three cases of infection with hepatitis C virus genotype 5 among Brazilian hepatitis patients. J Clin Microbiol 40(7): 2645-2647.
20. Holland PV, Barrera JM, Ercilla MG, Yoshida CF, Wang Y, et al. (1996) Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method. J Clin Microbiol 34(10): 2372-2378.
21. Corbet S, Bukh J, Heinsen A, Fomsgaard A (2003) Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients. J Clin Microbiol 41(3): 1091-1100.
22. Kusser W, Javorschi S, Gleeson MA Protocol of Real-Time RT-PCR:cDNA synthesis.
23. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24(8): 1596-1599.
24. Thompson WD, Walter SD (1988) Kappa and the concept of independent errors. J Clin Epidemiol 41(10): 969-970.